CYANOBACTERIAL NEUROTOXIN BETA-N-METHYLAMINO-L-ALANINE, SHARK FINS:
STUDY
*************************************************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases <http://www.isid.org>
Date: Tue 28 Feb 2012
Source: Asian Scientist, Rosenthal School of Marine & Atmospheric Science report [edited] <http://www.asianscientist.com/in-the-lab/neurotoxin-bmaa-shark-fin-alzheimers-lou-gehrig-disease-2012/>
BMAA neurotoxin found in shark fins linked to Alzheimer's disease
----------------------------------------------------------
Craving a bowl of shark fin soup? Think again. Researchers at the University of Miami have discovered high concentrations of beta-N-methylamino-L-alanine (BMAA) in shark fins, a neurotoxin linked to neurodegenerative diseases in humans including Alzheimer's and Lou Gehrig (also known as amyotrophic lateral sclerosis, ALS) diseases.
The findings, published in the journal Marine Drugs, suggests that consumption of shark fin soup and cartilage pills may pose a significant health risk for degenerative brain diseases.
A total of 7 species of shark were tested for this study: blacknose, blacktip, bonnethead, bull, great hammerhead, lemon, and nurse sharks, with samples collected from live animals in waters throughout South Florida.
"The concentrations of BMAA in the samples are a cause for concern, not only in shark fin soup, but also in dietary supplements and other forms ingested by humans," said co-author Professor Deborah Mash, Director of the University of Miami Brain Endowment Bank.
Prof Mash and her colleagues had published a study in 2009, demonstrating that patients dying with diagnoses of Alzheimer's disease and ALS had unusually high levels of BMAA in their brains of up to 256 ng/mg, whereas normal healthy aged people had no BMAA, or only trace quantities of the toxin present.
"BMAA was first linked to neurodegenerative diseases in Guam, which resulted in the progressive loss of structure and function of neurons," she said. In this latest study, the team found BMAA levels of between 144 and 1836 ng/mg in the fins, which overlapped with the levels measured in the brains of Alzheimer's and ALS patients.
Study co-author Dr Neil Hammerschlag hopes these findings will curb the practice of finning, whereby shark fins are removed at sea and the rest of the animal is thrown back in the water to die.
"Not only does this work provide important information on one probable route of human exposure to BMAA, it may lead to a lowering of the demand for shark fin soup and consumption of shark products, which will aid ocean conservation efforts," said Hammerschlag.
Reference
---------
Mondo K et al: Cyanobacterial Neurotoxin Beta-N-Methylamino-L-alanine
(BMAA) in Shark Fins. Mar. Drugs 2012; 10(2): 509-20; doi:10.3390/md10020509; available at <http://www.mdpi.com/1660-3397/10/2/509/>.
[Byline: Rebecca Lim]
--
Communicated by:
ProMED-mail
<promed@promedmail.org>
[Beta-N-Methylamino-L-alanine abbreviated as BMAA is a non-proteogenic amino acid produced by cyanobacteria. Cyanobacteria are also known as blue-green algae.
BMAA injected into rhesus monkeys has produced behavioral issues, muscle atrophy, and degeneration of neurons in the motor cortex.
It is thought that this protein complex closely resembles the protein alanine and becomes incorporated in a lethal fashion into the neurons.
In culture, neurological cells die when BMAA is incorporated into the cell.
The same problem, BMAA exists in products other than shark fin soup.
Industries have tried to capture the idea that a shark, an animal with a cartilaginous, not bony, skeleton does not get cancer. Consequently supplement industries boomed with various shark products. Now the safety of those products may be called into question. There are limited and unconfirmed reports of some supplements already found to contain BMAA. I have not been able to confirm those reports as being accurate. - Mod.TG]
..............................................sb/tg/mj/ml/ll
*##########################################################*
************************************************************
ProMED-mail makes every effort to verify the reports that are posted, but the accuracy and completeness of the
information, and of any statements or opinions based
thereon, are not guaranteed. The reader assumes all risks in
using information posted or archived by ProMED-mail. ISID
and its associated service providers shall not be held responsible for errors or omissions or held liable for any damages incurred as a result of use or reliance upon posted or archived material.
0 comments:
Post a Comment